Literature DB >> 2280769

Thyroid hormone receptors form distinct nuclear protein-dependent and independent complexes with a thyroid hormone response element.

M A Lazar1, T J Berrodin.   

Abstract

We have examined the binding of nuclear proteins and recombinant thyroid hormone receptors (TRs) to the palindromic thyroid hormone responsive element AGGTCATGACCT (TREp) using a gel electrophoretic mobility shift assay. Four specific protein-DNA complexes were detected after incubation of nuclear extracts (NE) from T3-responsive pituitary (GH3) cells with a TREp-containing DNA fragment. This was compared with the TREp binding of reticulocyte lysate-synthesized TRs. TR alpha 1 and TR beta 2 each formed a single major TR:TREp complex which comigrated with the least retarded complex formed by GH3 NE, while TR beta 1 formed multiple complexes suggesting that it can bind to TREp as an oligomer. Interestingly, coincubation of 35S-TR alpha 1, GH3 NE, and unlabeled TREp resulted in not only the 35S-TR:TREp complex, but in two additional more greatly retarded complexes containing 35S-TR alpha 1 and comigrating with those formed by GH3 extract alone. Incubation of each of the TRs with NE from COS-7 cells, which do not possess sufficient endogenous TRs to mediate T3-responses, resulted in formation of a new, more greatly shifted complex. A similar, heat labile activity which altered mobility of the TR:TRE complex was also present in NE from T3-unresponsive JEG-3 cells. At high concentration of NE, all of the TR bound to TREp was more greatly retarded than in the absence of NE. Truncation of TR alpha 1 at amino acid 210 prevented additional complex formation in the presence of NE without affecting DNA binding, suggesting that the carboxyl-terminus of the TRs is essential for interaction with nuclear proteins.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2280769     DOI: 10.1210/mend-4-11-1627

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  18 in total

1.  A retinoic acid-responsive element in the apolipoprotein AI gene distinguishes between two different retinoic acid response pathways.

Authors:  J N Rottman; R L Widom; B Nadal-Ginard; V Mahdavi; S K Karathanasis
Journal:  Mol Cell Biol       Date:  1991-07       Impact factor: 4.272

2.  Ligand-binding and heterodimerization activities of a conserved region in the ligand-binding domain of the thyroid hormone receptor.

Authors:  R A Spanjaard; D S Darling; W W Chin
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-01       Impact factor: 11.205

3.  Differential DNA binding by monomeric, homodimeric, and potentially heteromeric forms of the thyroid hormone receptor.

Authors:  M A Lazar; T J Berrodin; H P Harding
Journal:  Mol Cell Biol       Date:  1991-10       Impact factor: 4.272

4.  The orphan receptor Rev-ErbA alpha activates transcription via a novel response element.

Authors:  H P Harding; M A Lazar
Journal:  Mol Cell Biol       Date:  1993-05       Impact factor: 4.272

5.  Functional evidence for ligand-dependent dissociation of thyroid hormone and retinoic acid receptors from an inhibitory cellular factor.

Authors:  J Casanova; E Helmer; S Selmi-Ruby; J S Qi; M Au-Fliegner; V Desai-Yajnik; N Koudinova; F Yarm; B M Raaka; H H Samuels
Journal:  Mol Cell Biol       Date:  1994-09       Impact factor: 4.272

6.  The conserved ninth C-terminal heptad in thyroid hormone and retinoic acid receptors mediates diverse responses by affecting heterodimer but not homodimer formation.

Authors:  M Au-Fliegner; E Helmer; J Casanova; B M Raaka; H H Samuels
Journal:  Mol Cell Biol       Date:  1993-09       Impact factor: 4.272

7.  Recombinant thyroid hormone receptor and retinoid X receptor stimulate ligand-dependent transcription in vitro.

Authors:  I J Lee; P H Driggers; J A Medin; V M Nikodem; K Ozato
Journal:  Proc Natl Acad Sci U S A       Date:  1994-03-01       Impact factor: 11.205

8.  An arginine to histidine mutation in codon 311 of the C-erbA beta gene results in a mutant thyroid hormone receptor that does not mediate a dominant negative phenotype.

Authors:  M E Geffner; F Su; N S Ross; J M Hershman; C Van Dop; J B Menke; E Hao; R K Stanzak; T Eaton; H H Samuels
Journal:  J Clin Invest       Date:  1993-02       Impact factor: 14.808

9.  Retinoic acid-dependent transactivation of major histocompatibility complex class I promoters by the nuclear hormone receptor H-2RIIBP in undifferentiated embryonal carcinoma cells.

Authors:  T Nagata; J H Segars; B Z Levi; K Ozato
Journal:  Proc Natl Acad Sci U S A       Date:  1992-02-01       Impact factor: 11.205

10.  New insights on the mechanism(s) of the dominant negative effect of mutant thyroid hormone receptor in generalized resistance to thyroid hormone.

Authors:  P M Yen; A Sugawara; S Refetoff; W W Chin
Journal:  J Clin Invest       Date:  1992-11       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.